Globe & Mail 08:04 AM EDT, 04/05/2023 (MT Newswires) -- Opsens Inc. (OPS.TO), a cardiology-focused medical device company, said Wednesday that its SavvyWire solution has been successfully used by physicians in 1,000 procedures.
Opsens said SavvyWire is a sensor-guided solution for transcatheter aortic valve replacement procedures to treat aortic valve stenosis.
"The successful use of the SavvyWire in 1,000 patients marks an important milestone towards full-scale commercialization of our innovative device," President and CEO Louis Laflamme said.
"The early commercialization phase is progressing steadily and the impressive number of procedures completed demonstrates the acceptance and relevance of the SavvyWire within the structural heart market."